Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camillo Porta

Showing results (131-140 of 426) with videos related to

Pageof 43
Sort By:
Frontiers in Oncology|June 27, 2022
Molecular Aberrations Stratify Grade 2 Astrocytomas Into Several Rare Entities: Prognostic and Therapeutic ImplicationsValeria Internò, Giacomo Triggiano, Pierluigi De Santis, et al.
Cytotechnology|February 19, 2018
Culture in embryonic kidney serum and xeno-free media as renal cell carcinoma and renal cell carcinoma cancer stem cells research modelKrzysztof M Krawczyk, Damian Matak, Lukasz Szymanski, et al.
Future Oncology (London, England)|December 13, 2012
Sunitinib in advanced metastatic non-clear cell renal cell carcinoma: a single institution retrospective studyChiara Paglino, Ilaria Imarisio, Carlo Ganini, et al.
Future Oncology (London, England)|May 31, 2013
The treating scenario in genitourinary oncology: what is new? Part 2Sergio Bracarda, Rodolfo Montironi, Camillo Porta, et al.
Tumori|May 5, 2020
Use of a natural multicomponent mouthwash plus oral hygiene vs oral hygiene alone to prevent everolimus-induced stomatitis: the STOP multicenter, randomized trialCamillo Porta, Elena Verzoni, Silvia Zai, et al.
Expert Review of Neurotherapeutics|October 17, 2024
The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectivesEleonora Lauricella, Sofija Vilisova, Nada Chaoul, et al.
Expert Opinion on Biological Therapy|November 1, 2024
The future of cellular therapy for the treatment of renal cell carcinomaNada Chaoul, Eleonora Lauricella, Andrea Giglio, et al.
ESMO Open|March 25, 2020
Acute kidney injury from contrast-enhanced CT procedures in patients with cancer: white paper to highlight its clinical relevance and discuss applicable preventive strategiesLaura Cosmai, Camillo Porta, Carmelo Privitera, et al.
Expert Review of Anticancer Therapy|August 8, 2018
The role of tivozanib in advanced renal cell carcinoma therapyBernard Escudier, Camillo Porta, Tim Eisen, et al.
Anti-Cancer Agents in Medicinal Chemistry|July 23, 2013
Orai1 and transient receptor potential channels as novel molecular targets to impair tumor neovascularization in renal cell carcinoma and other malignanciesFrancesco Moccia, Silvia Dragoni, Valentina Poletto, et al.
Pageof 43

Showing results (131-140 of 426) with videos related to

Sort By:
Pageof 43
Frontiers in Oncology|June 27, 2022
Molecular Aberrations Stratify Grade 2 Astrocytomas Into Several Rare Entities: Prognostic and Therapeutic ImplicationsValeria Internò, Giacomo Triggiano, Pierluigi De Santis, et al.
Cytotechnology|February 19, 2018
Culture in embryonic kidney serum and xeno-free media as renal cell carcinoma and renal cell carcinoma cancer stem cells research modelKrzysztof M Krawczyk, Damian Matak, Lukasz Szymanski, et al.
Future Oncology (London, England)|December 13, 2012
Sunitinib in advanced metastatic non-clear cell renal cell carcinoma: a single institution retrospective studyChiara Paglino, Ilaria Imarisio, Carlo Ganini, et al.
Future Oncology (London, England)|May 31, 2013
The treating scenario in genitourinary oncology: what is new? Part 2Sergio Bracarda, Rodolfo Montironi, Camillo Porta, et al.
Tumori|May 5, 2020
Use of a natural multicomponent mouthwash plus oral hygiene vs oral hygiene alone to prevent everolimus-induced stomatitis: the STOP multicenter, randomized trialCamillo Porta, Elena Verzoni, Silvia Zai, et al.
Expert Review of Neurotherapeutics|October 17, 2024
The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectivesEleonora Lauricella, Sofija Vilisova, Nada Chaoul, et al.
Expert Opinion on Biological Therapy|November 1, 2024
The future of cellular therapy for the treatment of renal cell carcinomaNada Chaoul, Eleonora Lauricella, Andrea Giglio, et al.
ESMO Open|March 25, 2020
Acute kidney injury from contrast-enhanced CT procedures in patients with cancer: white paper to highlight its clinical relevance and discuss applicable preventive strategiesLaura Cosmai, Camillo Porta, Carmelo Privitera, et al.
Expert Review of Anticancer Therapy|August 8, 2018
The role of tivozanib in advanced renal cell carcinoma therapyBernard Escudier, Camillo Porta, Tim Eisen, et al.
Anti-Cancer Agents in Medicinal Chemistry|July 23, 2013
Orai1 and transient receptor potential channels as novel molecular targets to impair tumor neovascularization in renal cell carcinoma and other malignanciesFrancesco Moccia, Silvia Dragoni, Valentina Poletto, et al.
Pageof 43